News

DealMonitor: 468 invests in Gauss Robotics – Exazyme secures €2 million – D2C Angels bet on ingarden

Share This Post

Exazyme secures €2 million investment from AIX Ventures and Atlantic Labs. As a Berlin-based AI-Biotech startup, founded in 2022 by Ingmar Schuster, Philipp Markert, and Dr. Jelena Ivanovska, we leverage AI-based solutions to identify the optimal protein variations for diverse applications. Through training the AI with datasets, the team predicts the properties of novel protein variants.

Read full article here: https://www.deutsche-startups.de/2023/05/15/dealmonitor-gauss-robotics-exazyme/ 

DEUTSCHE STARTUPS, 15. Mai 2023